NCT02306590 Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis Status COMPLETED Phase NA
NCT02306109 Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase NA
NCT02290886 A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral Status COMPLETED Phase PHASE1/PHASE2
NCT02288091 A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE1
NCT02269436 A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS Status TERMINATED Phase PHASE1
NCT02242071 Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis Status WITHDRAWN Phase PHASE1
NCT02238626 Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT02236065 Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders Status COMPLETED Phase NA
NCT02166944 Tamoxifen Treatment in Patients With Motor Neuron Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02116634 Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis Status WITHDRAWN Phase PHASE1/PHASE2
NCT02059759 Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2 Status COMPLETED Phase PHASE2
NCT02058732 Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis Status TERMINATED Phase NA
NCT02039401 Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT02000713 Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS) Status TERMINATED Phase NA
NCT01999803 A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS Status TERMINATED Phase PHASE1